Skip to main content
Equibles

NATHBIOGEN · Nath Bio-Genes (India) Limited · Financials

Use NATHBIOGEN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NATHBIOGEN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
142.45 INR +2.15 (+1.53%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 3881 Avg daily vol (3M) 985

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
4.45B +22%
FY2026 Revenue FY2023–FY2026
Net Income
0
FY2026 Net Income FY2023–FY2026
Operating Cash Flow
-125.73M -171.5%
FY2026 Operating Cash Flow FY2023–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023
INR 4.9B 4.45B 3.65B 3.33B 3.01B
INR 39.94M 39.64M 38.16M 32.61M 30.12M
INR 170.56M 159.88M 104.84M 91.1M 101.21M
INR — 463.04M 405.85M 415.66M —
INR 47.34M 46.73M 19.85M 19.46M 11.53M
INR 0 0 0 0 350.27M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 114.02M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.